Skip to main content

Research Repository

Advanced Search

Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England.

Ajabnoor, Alyaa M; Parisi, Rosa; Zghebi, Salwa S; Ashcroft, Darren M; Faivre-Finn, Corinne; Morris, Charlotte; Mamas, Mamas A; Kontopantelis, Evangelos

Authors

Alyaa M Ajabnoor

Rosa Parisi

Salwa S Zghebi

Darren M Ashcroft

Corinne Faivre-Finn

Charlotte Morris

Evangelos Kontopantelis



Abstract

Background
The association between cancer and stroke or bleeding outcomes in atrial fibrillation is unclear. We sought to examine how certain types of cancer influence the balance between stroke and bleeding risk in patients with nonvalvular atrial fibrillation (NVAF).

Methods and Results
We estimated stroke and bleeding risk among adult patients with NVAF and certain types of cancer (breast, prostate, colorectal, lung, and hematological cancer) from 2009 to 2019 based on data from the UK Clinical Practice Research Datalink GOLD and Aurum databases. The control group included patients with NVAF only. Of 177 065 patients with NVAF, 11379 (6.4%) had cancer (1691 breast, 3955 prostate, 1666 colorectal, 2491 hematological, and 1576 lung). Compared with patients without cancer, stroke risk was higher in patients with breast cancer (adjusted hazard ratio [aHR], 1.20 [95% CI, 1.07–1.35) and with prostate cancer (aHR, 1.11 [95% CI, 1.01–1.12) if diagnosed within 6 months before NVAF. The risk of bleeding was increased in subjects with hematological cancer (aHR, 1.55 [95% CI, 1.40–1.71]), lung cancer (aHR, 1.49 [95% CI, 1.25, 1.77]), prostate cancer (aHR, 1.38 [95% CI, 1.28–1.49]), and colorectal cancer (aHR, 1.36 [95% CI, 1.21–1.53]), but not for subjects with breast cancer. The more recent the cancer diagnosis before NVAF diagnosis (within 6 months), the higher the risk of bleeding.

Conclusions
Breast and prostate cancer are associated with increased stroke risk, whereas in some cancer types, the risk of bleeding seemed to exceed stroke risk. In these patients, prescribing of oral anticoagulant should be carefully evaluated to balance bleeding and stroke risk.

Citation

Ajabnoor, A. M., Parisi, R., Zghebi, S. S., Ashcroft, D. M., Faivre-Finn, C., Morris, C., Mamas, M. A., & Kontopantelis, E. (2023). Common Cancer Types and Risk of Stroke and Bleeding in Patients With Nonvalvular Atrial Fibrillation: A Population-Based Study in England. Journal of the American Heart Association, 12(19), Article e029423. https://doi.org/10.1161/JAHA.123.029423

Journal Article Type Article
Acceptance Date Aug 8, 2023
Online Publication Date Sep 26, 2023
Publication Date Oct 3, 2023
Deposit Date Oct 23, 2023
Journal Journal of the American Heart Association
Electronic ISSN 2047-9980
Publisher Wiley Open Access
Peer Reviewed Peer Reviewed
Volume 12
Issue 19
Article Number e029423
DOI https://doi.org/10.1161/JAHA.123.029423
Keywords stroke, atrial fibrillation, cancer, oral anticoagulant, bleeding
Public URL https://keele-repository.worktribe.com/output/600963